title: Neuropsychological development of children born to patients with systemic lupus erythematosus.
abstract: To verify the neuropsychological development in the offspring of patients with systemic lupus erythematosus (SLE), 47 children (23 male and 24 female) from affected women were studied. The tests applied were related to the children's ages: Griffiths scale up to four years, WPPSI and metaphonological tests (MP, evaluating the phonological consciousness) from four to six years of age, WISC-R test and Rey test (evaluating the visual-space abilities) from six years onwards; finally, specific tests for the diagnosis of learning disabilities (LD) between the ages of seven and 13. Intelligence levels were always normal (mean IQ score 106.32; median 104; SD 9.05). Three out of eight examined children failed MP, therefore may develop LD and will need further evaluation later. Fourteen children were specifically studied for LD and three reported scores lower than normal, but only two (who were brothers) were defined dyslexic. Antiphospholipid antibodies (aPL) were positive in the mothers of the three children with impaired LD tests. Other maternal autoantibodies or drugs administered during pregnancy did not seem to be related to LD. In conclusion, maternal SLE does not impair intelligence levels, but may increase the occurrence of LD particularly in male children (2/8 males examined, 25%). Both maternal aPL and genetic background may have pathogenetic implications.
authors.affiliation: Pediatric Neuropsychiatry Institute, University of Brescia, Brescia, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Neri
authors.forename: L
authors.initials: L
authors.lastname: Chimini
authors.forename: F
authors.initials: F
authors.lastname: Bonomi
authors.forename: E
authors.initials: E
authors.lastname: Filippini
authors.forename: M
authors.initials: M
authors.lastname: Motta
authors.forename: D
authors.initials: D
authors.lastname: Faden
authors.forename: A
authors.initials: A
authors.lastname: Lojacono
authors.forename: C Biasini
authors.initials: CB
authors.lastname: Rebaioli
authors.forename: M
authors.initials: M
authors.lastname: Frassi
authors.forename: E
authors.initials: E
authors.lastname: Danieli
authors.forename: A
authors.initials: A
authors.lastname: Tincani
mesh_terms: D000293:Adolescent; D041923:Adolescent Development; D017152:Antibodies, Antiphospholipid / Q000097:blood; D002648:Child; D002657:Child Development; D016241:Child of Impaired Parents / Q000523:psychology; D002675:Child, Preschool; D005260:Female; D006801:Humans; D015994:Incidence; D007360:Intelligence; D007859:Learning Disabilities / Q000453:epidemiology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male; D009483:Neuropsychological Tests; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology; D011446:Prospective Studies
chemical_list: D017152:Antibodies, Antiphospholipid